Skip to main content
. 2012 Aug 1;7(8):e41358. doi: 10.1371/journal.pone.0041358

Table 1. Change in glargine dose, dose per weight, and HbA1c.

Baseline HbA1c Δ Dose Δ Dose/Weight Δ HbA1c
n Mean±SD n Mean±SD n Mean±SD
Overall 3506 3.5±4.8 2622 0.056±0.076 3187 −1.53±1.23
7.9≤HbA1c<8.5 775 2.6±3.9 565 0.044±0.066 701 −0.85±0.67
8.5≤HbA1c<9.0 580 3.0±4.3 432 0.049±0.069 529 −1.04±0.76
9.0≤HbA1c<9.5 526 3.5±4.5 403 0.055±0.069 478 −1.29±0.89
9.5≤HbA1c<10.0 483 4.0±4.9 358 0.062±0.073 445 −1.52±1.08
10.0≤HbA1c<10.5 330 4.0±4.5 246 0.063±0.071 295 −1.77±1.14
10.5≤HbA1c<11.0 303 4.2±5.1 221 0.064±0.075 268 −2.19±1.18
11.0≤HbA1c<11.5 197 4.2±6.2 153 0.068±0.105 186 −2.58±1.38
11.5≤HbA1c<12.0 152 4.1±5.5 117 0.061±0.087 136 −2.77±1.56
12.0≤HbA1c<12.5 160 5.0±6.7 127 0.078±0.108 149 −3.20±1.75